Masimo | MASI - Debt


Masimo reported $586.2M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Accuray USD 170.24M 4.52M Sep/2024
Align Technology USD 121.27M 1.75M Sep/2025
AngioDynamics USD 6.3M 6.3M Feb/2025
Artivion USD 317.78M 619K Dec/2024
AtriCure USD 76.73M 521K Sep/2025
Avanos Medical USD 133.7M 3.6M Sep/2025
Baxter International USD 9.71B 13M Sep/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Boston Scientific USD 12.05B 19M Sep/2025
Dexcom USD 1.24B 1.21B Dec/2025
Edwards Lifesciences USD 700.3M 2.3M Sep/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Globus Medical USD 119.34M 1.76M Sep/2025
Haemonetics USD 1.22B 54K Sep/2025
Inogen USD 0 0 Jun/2022
Insulet USD 1.01B 384.9M Sep/2025
Integra LifeSciences USD 2.01B 7.91M Sep/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 586.2M 56M Sep/2025
Medtronic USD 28.07B 1.03B Dec/2025
Orthofix International USD 137.23M 338K Sep/2024
Owens Minor USD 1.95B 91.18M Mar/2025
ResMed USD 846.35M 178.06M Sep/2025
Steris USD 2.06B 10.4M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.28M 276K Sep/2025
Teleflex USD 2.77B 774M Sep/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Zimmer Biomet Holdings USD 7.52B 593.5M Dec/2025